- Home
- PIII vs COCH Comparison
PIII vs COCH Comparison
Compare PIII & COCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PIII | COCH |
|---|---|---|
| Founded | 2015 | 1995 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Nursing Services | Blank Checks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.5M | 24.4M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | PIII | COCH |
|---|---|---|
| Price | $3.43 | $0.70 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 1 |
| Target Price | ★ $16.25 | $9.50 |
| AVG Volume (30 Days) | 10.3K | ★ 211.8K |
| Earning Date | 11-13-2025 | 11-10-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,444,952,000.00 | $208,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $14.85 | $29.53 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $3.50 | $0.64 |
| 52 Week High | $14.50 | $1.91 |
Technical Indicators
Market Signals| Indicator | PIII | COCH |
|---|---|---|
| Relative Strength Index (RSI) | 21.22 | 41.29 |
| Support Level | $3.51 | $0.67 |
| Resistance Level | $3.85 | $0.75 |
| Average True Range (ATR) | 0.25 | 0.06 |
| MACD | -0.03 | -0.01 |
| Stochastic Oscillator | 9.36 | 19.90 |
Price Performance
Historical ComparisonAbout PIII P3 Health Partners Inc.
P3 Health Partners Inc is a patient-centered and physician-led population health management company. P3's model aggregates and supports the community's existing healthcare resources to build a network of community providers working together to deliver coordinated and integrated care to patients with a shared commitment to improving patient outcomes, lowering cost, and delivering experience for all.
About COCH Envoy Medical Inc.
Envoy Medical Inc is a hearing health company focused on providing medical technologies. It is dedicated to pushing hearing technology beyond the status quo to provide patients with improved access, usability, independence and quality of life. The Company has one reportable segment: hearing. The hearing segment derives revenue from the sale of the Esteem FI-AMEI implants and replacement components to Esteem FI-AMEI implants.